Skip to main content

5 Result(s)

within N Gonzalez-Paz Remove this filter

and

  1. No Access

    Article

    Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

    Events mediating transformation from the pre-malignant monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) are unknown. We analyzed gene expression data sets generated on the Aff...

    W-J Chng, G F Huang, T H Chung, S B Ng, N Gonzalez-Paz, T Troska-Price… in Leukemia (2011)

  2. No Access

    Article

    Clinical and biological significance of RAS mutations in multiple myeloma

    W J Chng, N Gonzalez-Paz, T Price-Troska, S Jacobus, S V Rajkumar, M M Oken… in Leukemia (2008)

  3. No Access

    Article

    Genetic aberrations and survival in plasma cell leukemia

    Plasma cell leukemia (PCL) is an aggressive and rare hematological malignancy that originates either as primary disease (pPCL) or as a secondary leukemic transformation (sPCL) of multiple myeloma (MM). We repo...

    R E Tiedemann, N Gonzalez-Paz, R A Kyle, R Santana-Davila, T Price-Troska… in Leukemia (2008)

  4. No Access

    Article

    Clinical significance of TP53 mutation in myeloma

    W J Chng, T Price-Troska, N Gonzalez-Paz, S Van Wier, S Jacobus, E Blood… in Leukemia (2007)

  5. No Access

    Article

    Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

    The nonrandom recurrent nature of chromosome abnormalities in myeloma suggests a role for them in disease pathogenesis. We performed a careful cytogenetic analysis of patients with abnormal karyotypes (n = 254), ...

    C S Debes-Marun, G W Dewald, S Bryant, E Picken, R Santana-Dávila… in Leukemia (2003)